Passive Immunizing Drugs against Rabies Market Report – Research, Industry Analysis Reports and Market Demands

Global Passive Immunizing Drugs against Rabies Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Passive Immunizing Drugs against Rabies Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Rabies Immunoglobulin
- 1.3.3 Anti-rabies Serum
- 1.3.4 Rabies Virus Monoclonal Antibody
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Passive Immunizing Drugs against Rabies Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Category II Exposure
- 1.4.3 Category III Exposure
1.5 Global Passive Immunizing Drugs against Rabies Market Size & Forecast
- 1.5.1 Global Passive Immunizing Drugs against Rabies Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Passive Immunizing Drugs against Rabies Sales Quantity (2021-2032)
- 1.5.3 Global Passive Immunizing Drugs against Rabies Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Passive Immunizing Drugs against Rabies by Manufacturer

3.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Manufacturer (2021-2026)
3.2 Global Passive Immunizing Drugs against Rabies Revenue by Manufacturer (2021-2026)
3.3 Global Passive Immunizing Drugs against Rabies Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Passive Immunizing Drugs against Rabies by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Passive Immunizing Drugs against Rabies Manufacturer Market Share in 2025
- 3.4.3 Top 6 Passive Immunizing Drugs against Rabies Manufacturer Market Share in 2025
3.5 Passive Immunizing Drugs against Rabies Market: Overall Company Footprint Analysis
- 3.5.1 Passive Immunizing Drugs against Rabies Market: Region Footprint
- 3.5.2 Passive Immunizing Drugs against Rabies Market: Company Product Type Footprint
- 3.5.3 Passive Immunizing Drugs against Rabies Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Passive Immunizing Drugs against Rabies Market Size by Region
- 4.1.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2032)
- 4.1.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2032)
- 4.1.3 Global Passive Immunizing Drugs against Rabies Average Price by Region (2021-2032)
4.2 North America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.3 Europe Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.4 Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.5 South America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.6 Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
5.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2021-2032)
5.3 Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
6.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2021-2032)
6.3 Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2032)

7 North America

7.1 North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
7.2 North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
7.3 North America Passive Immunizing Drugs against Rabies Market Size by Country
- 7.3.1 North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
- 7.3.2 North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
8.2 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
8.3 Europe Passive Immunizing Drugs against Rabies Market Size by Country
- 8.3.1 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Passive Immunizing Drugs against Rabies Market Size by Region
- 9.3.1 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
10.2 South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
10.3 South America Passive Immunizing Drugs against Rabies Market Size by Country
- 10.3.1 South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
- 10.3.2 South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Passive Immunizing Drugs against Rabies Market Size by Country
- 11.3.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Passive Immunizing Drugs against Rabies Market Drivers
12.2 Passive Immunizing Drugs against Rabies Market Restraints
12.3 Passive Immunizing Drugs against Rabies Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Passive Immunizing Drugs against Rabies and Key Manufacturers
13.2 Manufacturing Costs Percentage of Passive Immunizing Drugs against Rabies
13.3 Passive Immunizing Drugs against Rabies Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Passive Immunizing Drugs against Rabies Typical Distributors
14.3 Passive Immunizing Drugs against Rabies Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Passive Immunizing Drugs against Rabies market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.
This report is a detailed and comprehensive analysis for global Passive Immunizing Drugs against Rabies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Passive Immunizing Drugs against Rabies market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Passive Immunizing Drugs against Rabies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Passive Immunizing Drugs against Rabies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kedrion Biopharma, Grifols, Sanofi Pasteur, Kamada, Zydus Lifesciences, Serum Institute of India, Sichuan Yuanda Shuyang Pharmaceutical, Sinopharm Group, Haffkine Bio-Pharmaceutical, Bharat Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Passive Immunizing Drugs against Rabies market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Rabies Immunoglobulin
Anti-rabies Serum
Rabies Virus Monoclonal Antibody
Market segment by Application
Category II Exposure
Category III Exposure
Major players covered
Kedrion Biopharma
Grifols
Sanofi Pasteur
Kamada
Zydus Lifesciences
Serum Institute of India
Sichuan Yuanda Shuyang Pharmaceutical
Sinopharm Group
Haffkine Bio-Pharmaceutical
Bharat Biotech
Sharon Bio-Medicine
Wuhan Institute of Biological Products
North China Pharmaceutical
Xingmeng Biopharmaceuticals (Suzhou)
Hualan Biological Engineering
Shanxi Kangbao Biological Product
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Passive Immunizing Drugs against Rabies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Passive Immunizing Drugs against Rabies, with price, sales quantity, revenue, and global market share of Passive Immunizing Drugs against Rabies from 2021 to 2026.
Chapter 3, the Passive Immunizing Drugs against Rabies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Immunizing Drugs against Rabies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Passive Immunizing Drugs against Rabies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Passive Immunizing Drugs against Rabies.
Chapter 14 and 15, to describe Passive Immunizing Drugs against Rabies sales channel, distributors, customers, research findings and conclusion.

Buy now